+ 0.89
+ 0.26%
+ 0.07
+ 0.02%
+ 0.75
+ 0.18%

Leading Edge Pharms Appoints Detroit Piston Legend John Salley As EVP Of Marketing

July 29, 2019 10:32 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cannabis-focused biotechnology company Leading Edge Pharms, Inc. said Monday former NBA champion John Salley has taken a role of Executive Vice President of the company.

Salley will manage the company’s CANNAVERA, the line of CBD-based topical pain and inflammation solutions. Aside from his professional basketball career, he is known to the public as a cannabis advocate and a longtime vegan.

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — Click here to learn more!

Leading Edge products are known for containing the company's proprietary compound Silvidiol, which enables CBD to get to the pain site voiding systematic absorption.

"I tried Leading Edge's topical oil for a chronic back pain issue that was keeping me awake at night," said Salley. "The bottom line is the product works. The oil eased my discomfort, allowing me to sleep through the night for the first time in years. As I learned more about the company, it became clear that behind the product was a commitment to the science of CBD and a natural approach to improving lives. I'm excited to join the team and look forward to building market momentum for Leading Edge and CANNAVERA."

Salley won two NBA titles with the Detroit Pistons, and one title each with the Los Angeles Lakers And Chicago Bulls.

Related Links:

4-Time NBA Champion John Salley Talks About His Cannabis Ventures

The Week Ahead In Cannabis: Sundial IPO, Earnings Take The Spotlight

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More

As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date. This week, however, stocks posted mixed performances. read more

J.R. Rahn Steps Down As MindMed CEO

Mind Medicine Inc. (NASDAQ: MNMD), more commonly known as MindMed, has announced co-founder and chief executive J.R. Rahn is stepping down from his leadership role, effective immediately. read more